نتایج جستجو برای: polysaccharide vaccine

تعداد نتایج: 127703  

Journal: :Allergologia et immunopathologia 2016
A Quezada L Maggi X Norambuena J Inostroza F Quevedo

BACKGROUND To analyse specific immune response to the 23-valent pneumococcal polysaccharide vaccine by measuring pneumococcal antibodies in children with asthma and with respiratory recurrent infection (RRI) as compared to healthy children. METHODS The study included 60 children, divided into three groups: 20 with asthma, 20 with RRI, and 20 healthy controls. Post-vaccination specific IgG ant...

Journal: :Infection and immunity 1973
B L Brandt M S Artenstein C D Smith

Over the past 4 years 19 lots of group C polysaccharide vaccine and five lots of group A polysaccharide vaccine have been tested for their immunogenicity in man. For each lot tested, groups of 18 to 50 men received 50 mug of vaccine subcutaneously. Sera were obtained prior to and 2 weeks after vaccination. The analytical and serological methods used in these studies were Sepharose 4B chromatogr...

2014
Cyrus H. Simanjuntak

Typhoid fever is highly enclemic in Indonesia with the incidence range from 360 cases (semirural area) to 810 cases (urban area) per 100,000 population per year The conventional whole cell vaccine which is parenteral, has long been known and used in Indonesia. Since 1960's immunization with this conventional yaccine was terminated from the vaccine program for infants, due to its annoying and in...

Journal: :The Journal of clinical investigation 1994
L C Madoff L C Paoletti J Y Tai D L Kasper

Group B streptococcal infection is a major cause of neonatal mortality. Antibody to the capsular polysaccharide protects against invasive neonatal disease, but immunization with capsular polysaccharides fails to elicit protective antibody in many recipients. Conjugation of the polysaccharide to tetanus toxoid has been shown to increase immune response to the polysaccharide. In animal models, C ...

Journal: :Bulletin of the World Health Organization 2001
H H Yang C G Wu G Z Xie Q W Gu B R Wang L Y Wang H F Wang Z S Ding Y Yang W S Tan W Y Wang X C Wang M Qin J H Wang H A Tang X M Jiang Y H Li M L Wang S L Zhang G L Li

OBJECTIVE To test the efficacy of locally produced Vi vaccine over a time period of longer than one year. METHODS A double-blinded, randomized field trial was performed in Guangxi Zhuang Autonomous Region in south-western China, using 30 micrograms doses of locally produced Vi. Enrolled subjects were 3-50 years of age, although the majority (92%) were school-aged children, who have the highes...

Journal: :Clinical and vaccine immunology : CVI 2016
Ioanna Papadatou Vana Spoulou

Controversy exists regarding the optimal use of the 23-valent pneumococcal conjugate vaccine for the protection of high-risk individuals, such as children and adults with immunocompromising conditions and the elderly. The effectiveness and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) are limited in such high-risk populations compared to the healthy, with meta-analyses...

Journal: :Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2006
Yew Kuang Cheng Paul A Decker Megan M O'Byrne Catherine R Weiler

BACKGROUND There are limited studies of large cohorts of patients with specific polysaccharide antibody deficiency (SPAD) syndrome. OBJECTIVE To study the clinical and laboratory characteristics of patients with specific polysaccharide antibody deficiency syndrome. METHODS We retrospectively studied 75 patients with total IgG levels of at least 500 mg/dL and fewer than 9 of 12 responses to ...

Journal: :Journal of immunology 2005
Goutam Sen Abdul Q Khan Quanyi Chen Clifford M Snapper

We determined whether T cell-independent Ig isotype responses to isolated pneumococcal polysaccharides (PPS) required TLR signaling in vivo. IgG anti-PPS responses to PPS3, PPS14, and C-polysaccharide (C-PS) were virtually undetectable in TLR2(-/-) mice, whereas specific IgM induction was variably reduced compared with wild-type mice. All PPS-containing preparations induced IL-6 and TNF-alpha f...

Journal: :New South Wales public health bulletin 2012
Deepika Mahajan Su Reid Jane Cook Kristine Macartney Robert I Menzies

AIM This report summarises Australian passive surveillance data for adverse events following immunisation in NSW for 2011. METHODS Analysis of de-identified information on all adverse events following immunisation reported to the Therapeutic Goods Administration. RESULTS 449 adverse events following immunisation were reported for vaccines administered in 2011; this is slightly higher than i...

2016
C. Sadlier S. O’Dea K. Bennett J. Dunne N. Conlon C. Bergin

The aim of this study was to compare the immunologic response to a prime-boost immunization strategy combining the 13-valent conjugate pneumococcal vaccine (PCV13) with the 23-valent polysaccharide pneumococcal vaccine (PPSV23) versus the PPSV23 alone in HIV-infected adults. HIV-infected adults were randomized to receive PCV13 at week 0 followed by PPSV23 at week 4 (n = 31, prime-boost group) o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید